Idiopathic pulmonary fibrosis: Immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 1, 2012, Pages 58-71

  Lomas, Nicola J ^a,b   Watts, Keira L ^b   Akram, Khondoker M ^b   Forsyth, Nicholas R ^b   Spiteri, Monica A ^a  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

Epithelial mesenchymal transition; Idiopathic pulmonary fibrosis; Immunohistochemistry; Prognostic markers; Tissue repair and remodelling

Indexed keywords

ARTICLE; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSING ALVEOLITIS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROGNOSIS;

EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOHISTOCHEMISTRY; PROGNOSIS;

EID: 84856706398     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Gribben J, Hubbard RB, Le-Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006 14;61:980-985.
2. Nicholson AG, Fulford LG, Colby TV, du Bois RM, Hansell DM, Wells AU. The relationship between individual histologic features and disease progression in IPF. Am J Respir Crit Care Med 2002 15:166:173-177.
3. King TE Jr, Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA Jr, Flint A, Thurlbeck W, Cherniak RM. Am J Respir Crit Care Med. 2001; 164(6): 1025-1032.
4. Barlo NP, van Moorsel CH, van den Bosch JM, Grutters JC. Predicting prognosis in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2010; 27(2): 85-95
5. Maher TM, Wells AU and Laurent GJ. Idiopathic pulmonary fibrosis: multiple causes and mechanisms? EurRespir J 2007; 30 (5):835-839.
6. Phan SH. The myofibroblast in pulmonary fibrosis. Chest 2002; 122(6 suppl):286s-289s.
7. Lama VN, Phan SH. The extra pulmonary origin of fibroblasts: stem/progenitor cells and beyond. Proc Am Thorac Soc 2006; 3:373-376.
8. Hashimoto N, Phan SH, Imaizumi K, Matsuo M, Nakashima H, Kawabe T, Shimokata K, Hasegawa Y. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2010; 43(2):161-172.
9. Willis BL, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, du Bois RM, Borok Z. Induction of epithelial-mesenchymal transition in alveolar epithelium cells by transforming growth factor-beta 1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 2005; 166:1321-1332.
10. Kim KK, Kulger MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman HA. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U.S.A. 2006 6;103:13180-13185.
11. Hay ED. An overview of epithelialmesenchymal transition. Act Anat (Basel) 1995;154:8-20.
12. De Wever O, Westbroek W, Verloes A, Bloemen N, Bracke M, Gespach C, Brugneel E, Mareel M. Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-β or wounding. J Cell Sci 2004 15;117:4691-4703.
13. Willis BC and Borok Z. TGF-β induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007;10:1152.
14. Potenta S, Zeisberg E, Kalluri R. The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 2008 4;99:1275-1279.
15. Zeisberg Em, Tarnavski D, Zeisberd M, Dorfman AL, Mcmullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007 29;13:952-961
16. Zeisberg M, Yang, C, Martino M, Duncan MB, Rieder F, Tanjore H, Kalluri R. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007 10;282:23337-23347.
17. Harada T, Nabeshima K, Hamasaki M, Uesugi N, Watanabe K, Iwasaki H. Epithelialmesenchymal transition in human lungs with usual interstitial pneumonia: quantitative immunohistochemistry. Pathol Int 2010;60 (1):14-21.
18. Pozhaeskaya V, Torres-Gonzalez E, Rojas M, Gal A, Amin M, Dollard S, Roman J, Stecenko AA, Mora AL. TWIST: A regulator of epithelialmesenchymal transition in lung fibrosis. PLos ONE 2009 23;4(10):e7559.
19. Sun S, Ning X, Zhang Y, Lu Y, Nie Y, Han S, Liu L, Du R, Xia L, He L, Fan D. Hypoxia-inducible factor-1 alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int 2009;75(12):1278-1287.
20. Desmouliere A, Geinoz A, Gabbiani F. Transforming growth factor-beta 1 induces alpha - smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993 1;122(1):103-111.
21. Bartram U, Speer CP. The role of transforming growth factor beta in lung development and disease. Chest 2004;125(2):754-765.
22. Shintani Y, Maeda M, Chaika N, Johnson KR, Wheelock MJ. Collagen 1 promotes epithelialto-mesenchymal transition in lung cancer cells via Transforming Growth Factor-β signaling. Am J Respir Cell Mol Biol 2008;38:95-104.
23. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cerdier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigriss JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkah T, Kim DS, King TE Jr, Kondoh Y, Myers J, Mülliner NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ. An official ATS/ERS/JRS/ACAT statement: Idiopathic Pulmonary Fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011 15;183:788-824.
24. Zhou L, Lim L, Costa RH Whitsett JA. Thyroid transcription factor-1 hepatocyte nuclear fctor-3 beta, surfactant protein B, C and Clara cells secretory protein in developing mouse lung. Am J Pathol 1994;145:114-125.
25. Godin I, Whlie CC. TGF beta 1 inhibits proliferation and has a chemotropic effect on mouse primordial germ cells in culture. Development 1991;113(4):1451-1457.
26. Zhang K, Rekhter MD, Gorden D, Phan SH. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis: A combined immunohistochemical and in situ hybridization study. Am J Pathol 1994;145: 114-125.
27. Bullwinkel J, Baron-Luhr B, Ludemann A, Wohlenberg C, Gerdes J, Scholzen J. Ki67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol 2006;206:624-635.
28. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993 13;336:704-707.
29. Harvey J M, Clark GM, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17 (5):1474-1481.
30. Cohen J. Statistical power analysis for the behavioral sciences. New Jersey: Lawrence Erlbaum Ass. 1988.
31. Kim JH, Jang YS, Eom KS, Hwang Y II, Kang HR, Jang SH, Kim CH, Park YB, Lee MG, Hyun IG, Jung K, Kim D. Transforming growth factor β1 induces epithelial-to-mesenchymal transition of A549 cells. J Korean Med Sci 2007 31;22:898-904.
32. Yamada M, Kuwano K, Maeyama T, Hamada N, Yoshimi M, Nakanishi Y, Kasper M. Dualimmunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary fibrosis. Histochem Cell Biol 2008; 129:453-462.
33. Lawson WE, Grant SW, Ambrosini V, Womble KE, Dawson EP, Lane KB, Markin C, Renzoni E, Lymphany E, Thomas AQ, Roldon J, Scott TA, Blackwell TS, Phillips JA 3rd, Loyd JE, du Bois RM. Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 2004;59:977-980.
34. Lawson WE, Polosukhin VV, Stathopoulos GT, Zoia O, Han W, Lane KB, Li B, Donnelley EF, Holburn GE, Lewis KG, Collins RD, Hull WM, Glasser SW, Whitsett JA, Blackwell TS. Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratrachealbleomycin. Am J Pathol 2005; 167:1267-1276.
35. Chilosi M, Poletti V, Murer B, Lestani M, Montagna L, Piccoli P, Pedron S, Bertaso M, Scarpa A, Murer B, Cancellieri A, Maestro R, Semenzato G, Dogliono C. Abnormal rerepithelialization and lung remodeling in Idiopathic Pulmonary Fibrosis: The role of ΔN-p63. Lab Invest 2002;82:1335-1345.
36. Hinz B, Pittet P, Smith-Clerc J, Chaponnier C, Meister J-J. Myofibroblast development is characterized by specific cell-cell adherens junctions. Mol Biol Cell 2004;15:4310-4320.
37. Chambers RC, Leoni P, Kaminski N, Laurent GJ, Heller RA. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotype switching. Am J Pathol 2003;162:533-546.
38. Sides MD, Klingsberg RC, Shan B, Gordon KA, Nquyen HT, Lin Z, Takahashi T, Flemmington EK, Lasky JA. The Epstein-Barr virus latent membrane protein 1 and transforming growth factor-β1 synergistically induce epithelialmesenchymal transition in lung epithelial cells. Am J Respir Cell Mol Biol 2011;44:852-862.